ArticlePloS one2026
AdaptiveInvolutionNet: Spatially-adaptive involution with channel-wise attention for breast MRI tumor classification.
Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundEarly and accurate classification of breast tumors from MRI scans is essential for improving patient outcomes. However, a key limitation of conventional deep learning models, such as Convolutional Neural Networks (CNNs), is their difficulty in capturing the subtle, spatially variant features that are crucial for precise medical image interpretation.
objectiveTo address this limitation, we propose a novel deep learning framework called AdaptiveInvolutionNet (AIN). This hybrid architecture is specifically designed to improve discriminative feature learning for breast tumor classification by integrating two key mechanisms: spatially-adaptive involution layers and channel-wise attention.
methodsOur AIN model employs a unique strategy for feature extraction. In its early layers, it utilizes spatially-adaptive involution kernels, which are highly effective at capturing fine-grained, localized features. As the network deepens, it transitions to conventional convolutions to maintain computational efficiency. To further enhance its diagnostic capabilities, we have embedded channel-wise attention mechanisms (specifically, squeeze-and-excitation modules) within the residual connections of the network. This allows the model to dynamically and selectively amplify diagnostically relevant features while suppressing less important ones. The model was rigorously trained and evaluated on a large, balanced dataset of 6,000 breast MRI images (3,000 benign, 3,000 malignant) using a robust five-fold cross-validation protocol.
resultsAIN demonstrated superior performance, achieving a high test accuracy of 97%. This performance was consistent and reliable across all folds, with an average accuracy of 96% (± 1%). The model also showed strong agreement with true labels, indicated by a high Cohen's Kappa score of 0.93 (± 0.01), and produced well-calibrated, trustworthy predictions with a low Brier score of just 0.0241.
conclusionBy successfully uniting an adaptive spatial feature extraction method with powerful attention mechanisms, AIN represents a significant advancement in medical image analysis. Its high accuracy, robust generalization, and consistent reliability demonstrate a strong potential for it to serve as a valuable and dependable computer-aided diagnostic tool for breast cancer detection in clinical settings.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.